Daily Health Headlines

Blacks Account for More Than Half of New HIV Diagnoses: CDC

👤by Robert Preidt 0 comments 🕔Friday, February 6th, 2015

THURSDAY, Feb. 5, 2015 (HealthDay News) -- Blacks are diagnosed with HIV more often than any other group of Americans, and while their death rate from the disease is declining, it is still higher than in other racial/ethnic group.

Those are the findings of two new U.S. government studies reported Thursday. The findings show the need to redouble efforts to provide black Americans with better HIV prevention, diagnosis and care, the researchers, from the Centers for Disease Control and Prevention (CDC), said.

The first study involved an analysis of data from CDC-funded HIV testing in 61 regions across the country in 2013. Blacks accounted for 45 percent of people tested for HIV, the largest proportion of any racial/ethnic group.

Blacks also accounted for nearly 55 percent of all new HIV diagnoses. Among blacks diagnosed with HIV, gay men accounted for about 37 percent of the new diagnoses, according to the study.

The researchers also found significant gaps in care for blacks diagnosed with HIV. For example, only about 54 percent of newly diagnosed blacks were referred to HIV prevention services.

The second study found that deaths among blacks with HIV fell 28 percent from 2008 to 2012 in the United States, while the overall decline in the death rate for people with HIV dropped 22 percent. Hispanics with HIV saw a 25 percent decline in deaths, compared to a 13 percent drop among whites with HIV.

Despite the largest decline, the death rate for blacks with HIV in 2012 was 13 percent higher than the rate for whites and 47 percent higher than the rate for Hispanics.

The authors of the studies noted in a CDC news release that blacks comprise 12 percent of the U.S. population, but more than one-third of those with HIV in the United States. And, while there has been progress in HIV testing, 15 percent of blacks with HIV don't know they have the infection, and many who have been diagnosed do not receive care and treatment.

Both studies appear in the Feb. 6 issue of the CDC's Morbidity and Mortality Weekly Report.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: U.S. Centers for Disease Control and Prevention, news release, Feb. 5, 2015

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More HIV Articles

Drug Combo Shows Early Promise for Remission of HIV

Drug Combo Shows Early Promise for Remission of HIV0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Animal research with an experimental two-drug therapy could hold clues for creating long-term HIV remission in people living with the virus, a new report says. The goal: to free patients from the need ...

Antibodies May Hold Key to HIV Suppression

Antibodies May Hold Key to HIV Suppression0

WEDNESDAY, Nov. 9, 2016 (HealthDay News) -- Antibodies may keep the HIV virus in check and one day let patients stop taking antiretroviral drugs, two new preliminary trials suggest. Researchers tried to quell HIV in 23 patients with infusions ...

Experimental Medicine Might Rescue People With Drug-Resistant HIV

Experimental Medicine Might Rescue People With Drug-Resistant HIV0

FRIDAY, Oct. 28, 2016 (HealthDay News) -- Researchers report that a new medication might revolutionize the treatment of HIV patients who don't respond to existing drugs. The intravenous drug, known as ibalizumab, is given every two weeks. It's ...

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- Using genetic analyses of 40-year-old blood samples, scientists have arrived at a clearer understanding of the introduction and spread in North America of the virus that causes AIDS. One myth already ...

HIV May Hide in Tissues, Even After Treatment

HIV May Hide in Tissues, Even After Treatment0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- HIV patients who've been treated with antiretroviral drugs still have the AIDS-causing virus in their tissues, a new study suggests. Treatment with antiretrovirals eliminates detectable levels of HIV ...

View More HIV Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!